Reply: Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib
ANNALS OF PHARMACOTHERAPY, vol.50, no.4, pp.336, 2016 (SCI-Expanded, Scopus)
- Publication Type: Article / Letter
- Volume: 50 Issue: 4
- Publication Date: 2016
- Doi Number: 10.1177/1060028016629981
- Journal Name: ANNALS OF PHARMACOTHERAPY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.336
- Hacettepe University Affiliated: Yes